Company intelligence / Profile preview

Aimil Pharmaceuticals

New Delhi, Delhi, Indiaaimil.com ↗
Ownership
Private
Development stage
Other
01

Overview

Aimil Pharmaceuticals is a leading Indian company specializing in scientifically validated Ayurvedic medicines and natural healthcare products. The company has developed several market-leading brands for chronic and lifestyle diseases such as diabetes (BGR–34), chronic kidney disease (Neeri KFT), leucoderma/vitiligo (Lukoskin), and others. Many of its formulations are developed in collaboration with top Indian research institutions like CSIR and DRDO. Its products are available globally across more than thirty countries, with strong clinical validation for key brands such as BGR–34 and Lukoskin.

Therapeutic areas
Infectious DiseasesDermatologyGastroenterologyEndocrinologyHematologyNephrology
Modalities
Herbal medicineAyurvedic formulationSmall molecule (plant-derived)
Industry
Biotech
02

Drug pipeline

3 assets

BGR-34

Unknown

2 more assets in the full pipeline.

Request access →
03

Partnerships

Council of Scientific & Industrial Research [CSIR]Defence Research & Development Organisation [DRDO]Indian Veterinary Research Institute [IVRI]Tata Memorial Centre Advanced Centre for Treatment, Research & Education in Cancer [TATA ACTREC]

Beyond the preview

Go deeper on Aimil Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aimil Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call